Home > Learn > Research Library > TIRZEPATIDE
Tirzepatide is a dual GIP and GLP-1 receptor agonist
peptide investigated for its potential to improve metabolic health, support glucose regulation, and promote significant weight management.

Tirzepatide is a synthetic peptide that acts as an agonats at both GIP-1
and GLP-1 receptors. By targeting these incretin pathways, it may help
improve glycemic control, reduce appetite, and support weight loss.
This guide is provided for educational and research purposes only.

Research on satiety signaling and reduced food intake through amylin receptor activation.

Studies investigating its potential to support fat loss and body weight control.

Research on glucose metabolism, insulin sensitivity. and metabolic function.

Investigations into improved glycemic control and postprandial response.
Dual GIP & GLP-1 agonist
Stimulates GIP and GLP-1 receptors
Enhances insulin secretion and satiety signaling
Delays gastric emptying and reduces food intake
Supports weight management and metabolic health.

Dual GIP & GLP-1 agonist

Stimulates GIP and GLP-1 receptors

Enhances insulin secretion and satiety signaling

Delays gastric emptying and reduces food intake

Supports weight management and metabolic health

Targets both GIP and GLP-1 receptors for enhanced metabolic and weight management potential.

Research indicates Tirzepatide may promote significant weight loss and improve body composition.

Studies suggest benefits for glucose control, insulin sensitivity, lipid profile, and overall metabolic health.

Browse our library of research guides on peptides and compounds studied in advanced science.

Every batch tested for purity and conisstency.

Fast & secure
delivery.

For laboratory research purposes.

Supplying compounds for advanced research.

You must be at least 21 years old to enter this website.
By clicking "Confirm & Enter", you confirm that you are 21 years of age or older and understand that all products sold on this website are intended for research purposes only.